Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.
暂无分享,去创建一个
D. Elder | D. Snodin | D P Elder | D Snodin | A Teasdale | A. Teasdale
[1] N. Cauchon,et al. Hydrophilic interaction liquid chromatography with alcohol as a weak eluent. , 2009, Journal of chromatography. A.
[2] R. S. Chaudhary,et al. High-performance thin-layer chromatographic method for monitoring degradation products of rifampicin in drug excipient interaction studies , 1994 .
[3] D. F. Bain,et al. Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] B. Glickman,et al. Mutational specificities of environmental carcinogens in the lacl gene of Escherichia coli H. V: DNA sequence analysis of mutations in bacteria recovered from the liver of swiss mice exposed to 1,2‐dimethylhydrazine, azoxymethane, and methylazoxymethanolacetate , 1991, Molecular carcinogenesis.
[5] A. Chakraborti,et al. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. , 2007, Journal of pharmaceutical and biomedical analysis.
[6] E. Wang,et al. Detection of hydrazine, methylhydrazine, and isoniazid by capillary electrophoresis with a palladium-modified microdisk array electrode. , 1996, Analytical chemistry.
[7] L. Capitán-Vallvey,et al. Solid-phase spectrophotometric determination of trace amounts of hydrazine at sub-ng ml−1 level , 1997 .
[8] David Q. Liu,et al. A generic approach for the determination of trace hydrazine in drug substances using in situ derivatization-headspace GC-MS. , 2009, Journal of pharmaceutical and biomedical analysis.
[9] C. L. Narayana,et al. A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs. , 2000, Journal of pharmaceutical and biomedical analysis.
[10] A. Viksna,et al. Application of hydrophilic interaction chromatography for simultaneous separation of six impurities of mildronate substance. , 2008, Journal of pharmaceutical and biomedical analysis.
[11] J. Vessman,et al. Determination of hydrazine in hydralazine by capillary gas chromatography with nitrogen-selective detection after benzaldehyde derivatization. , 1990, Journal of Chromatography A.
[12] I. Schmeltz,et al. Chemical studies on tobacco smoke. Quantitative analysis of hydrazine in tobacco and cigarette smoke. , 1974, Analytical chemistry.
[13] D. Elder,et al. Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals. , 2010, Journal of pharmaceutical and biomedical analysis.
[14] A Carlin,et al. Stability of isoniazid in isoniazid syrup: formation of hydrazine. , 1998, Journal of pharmaceutical and biomedical analysis.
[15] E. G. Lovering,et al. Determination of hydrazine in pharmaceuticals IV: Hydrazine and benzylhydrazine in isocarboxazid. , 1985, Journal of pharmaceutical sciences.
[16] D. Elder,et al. Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.
[17] J. Klimeš,et al. HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers. , 2008, Journal of pharmaceutical and biomedical analysis.
[18] Saranjit Singh,et al. Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin. , 2003, Journal of pharmaceutical and biomedical analysis.
[19] D. Elder,et al. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.
[20] R. W. Sears,et al. High-performance liquid chromatographic determination of isoniazid and 1-isonicotinyl-2-lactosylhydrazine in isoniazid tablet formulations. , 1980, Journal of pharmaceutical sciences.
[21] E. G. Lovering,et al. Determination of hydrazine in pharmaceuticals III: hydralazine and isoniazid using GLC. , 1983, Journal of pharmaceutical sciences.
[22] N. Jagota,et al. Determination of trace levels of hydrazine in the penultimate intermediate of a novel anti-infective agent. , 1998, Journal of pharmaceutical and biomedical analysis.
[23] S. De Flora,et al. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. , 1981, Cancer research.
[24] Y. Kumar,et al. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor. , 2004, Journal of pharmaceutical and biomedical analysis.
[25] L. Niu,et al. Detection of hydrazine, methylhydrazine and isoniazid by capillary electrophoresis with a 4-pyridyl hydroquinone self-assembled microdisk platinum electrode. , 1999, Journal of pharmaceutical and biomedical analysis.
[26] J. Klimeš,et al. HPLC study on stability of pyridoxal isonicotinoyl hydrazone. , 2006, Journal of pharmaceutical and biomedical analysis.
[27] K. Altria,et al. Quantitative microemulsion electrokinetic capillary chromatography analysis of formulated drug products , 2001 .
[28] M. Srinivasu,et al. Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC. , 2002, Journal of pharmaceutical and biomedical analysis.
[29] T. Matsushima,et al. Relationships between chemical structures and mutagenicity: a preliminary survey for a database of mutagenicity test results of new work place chemicals. , 2001, Industrial health.
[30] G. Font,et al. Fluorimetric determination of hydrazine in isoniazid formulations with 2-hydroxy-1-naphthaldehyde. , 1988, Journal of pharmaceutical and biomedical analysis.
[31] A. G. Davidson. Assay of hydrazine in isoniazid and its formulations by difference spectrophotometry. , 1982, The Analyst.
[32] P. Madhavan,et al. Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate. , 2006, Journal of pharmaceutical and biomedical analysis.
[33] M. B. Devani,et al. Spectrophotometric determination of isoniazid in presence of its hydrazones. , 1978, Journal of pharmaceutical sciences.
[34] Bernard Testa,et al. Drug Metabolism: Chemical and Biochemical Aspects , 1976 .
[35] D. C. Zhao,et al. Interactions between drug substances and excipients. 1. Fluorescence and HPLC studies of triazolophthalazine derivatives from hydralazine hydrochloride and starch. , 1996, Journal of pharmaceutical sciences.